Manner Carrie Eglinton - 07 Mar 2022 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Reporting relationship: SVP, Advanced Diagnostics
Issuer ticker: DGX
Reported as of: 07 Mar 2022
Net transaction value: +$1,068,689
SEC form: 4
Accepted by SEC: 09 Mar 2022, 15:44:42 UTC
Prior SEC filing: 28 Feb 2022
Next SEC filing: 15 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ William J. O'Shaughnessy, Jr., as attorney-in-fact for Carrie Eglinton Manner

Key filing fact

Manner Carrie Eglinton filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 09 Mar 2022.

Key facts

This page summarizes Manner Carrie Eglinton's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 09 Mar 2022, 15:44.

Change

Previous filing in this sequence was filed on 28 Feb 2022.
Current net transaction value: +$1,068,689.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DGX transaction

Common Stock

Award

Transaction value: $2,102,515
Shares: +16,162
Change %: +40%
Price: $130.09
Shares after: 56,338
Date: 07 Mar 2022
Ownership: Direct
Footnotes: F1

DGX transaction

Common Stock

Tax liability

Transaction value: $1,033,825
Shares: -7,947
Change %: -14%
Price: $130.09
Shares after: 48,391
Date: 07 Mar 2022
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d).

Footnote F2

Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.